KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Current Leases (2021 - 2025)

Historic Current Leases for Castle Biosciences (CSTL) over the last 5 years, with Q3 2025 value amounting to $1.4 million.

  • Castle Biosciences' Current Leases fell 1696.28% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year decrease of 1696.28%. This contributed to the annual value of $1.7 million for FY2024, which is 4643.8% up from last year.
  • According to the latest figures from Q3 2025, Castle Biosciences' Current Leases is $1.4 million, which was down 1696.28% from $1.6 million recorded in Q2 2025.
  • Castle Biosciences' Current Leases' 5-year high stood at $2.0 million during Q2 2023, with a 5-year trough of $1.1 million in Q3 2023.
  • In the last 5 years, Castle Biosciences' Current Leases had a median value of $1.4 million in 2025 and averaged $1.4 million.
  • Per our database at Business Quant, Castle Biosciences' Current Leases skyrocketed by 6234.52% in 2023 and then tumbled by 3763.99% in 2024.
  • Quarter analysis of 5 years shows Castle Biosciences' Current Leases stood at $1.2 million in 2021, then soared by 50.72% to $1.8 million in 2022, then plummeted by 36.02% to $1.1 million in 2023, then soared by 46.44% to $1.7 million in 2024, then fell by 12.97% to $1.4 million in 2025.
  • Its Current Leases was $1.4 million in Q3 2025, compared to $1.6 million in Q2 2025 and $1.4 million in Q1 2025.